Drug research

ALTO-203 25 μg

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593	Alto Neuroscience	Phase 2	Completed	2025-04-14Actual

Alto NeuroscienceCompletedPrimary completion: 2025-04-14 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.